MEDBRIDGE: AI-Driven Risk Stratification and Care Transition Intervention to Improve Diabetes Medication Management
Sponsor: University of Alabama at Birmingham
Trial Details
| Condition | Type 2 Diabetes, Medication Adherence, Care Transition, Medication Discrepancy |
| Intervention | MEDBRIDGE-Guided NCM/CHW Post-Discharge Support Intervention |
| Phase | NA |
| Status | Not_yet_recruiting |
| Participants | 45 |
| Est. Completion | 30 Apr 2030 |
| Last Updated | 20 May 2026 |
Primary Outcome
Recruitment Rate; Retention Rate; Patient Acceptability; Intervention Fidelity
Eligibility Criteria
Inclusion Criteria
Inclusion Criteria: * Adults aged 18 years or older * Diagnosis of type 2 diabetes (HbA1c of 6.5% or higher or relevant ICD-10 codes including E11, E13, E14, R73, L97.509, K31.84) * Discharged from UAB Hospital or its emergency departments * Receiving primary care at Cooper Green Mercy Health Services or UAB Post Discharge Clinic * Identified as high risk by the MEDBRIDGE prediction tool based on elevated risk of HbA1c elevation, diabetes-related emergency department visits, or diabetes-related hospitalizations within 3 months post-discharge Exclusion Criteria: * Under age 18 * No indication of type 2 diabetes * Not affiliated with Cooper Green Mercy Health Services or UAB Post Discharge Clinic for primary care * Unable to provide informed consent * Currently enrolled in another post-discharge intervention study
Trial Sites
Countries
This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service